Azoospermia: Incidence, and biochemical evaluation of seminal plasma by the differential pH method

Panminerva Medica

Volumn 42, Issue 1, 2000, Pages 27-31

  Mazzilli, F ^a   Rossi, T ^a   Delfino, M ^a   Sarandrea, N ^a   Dondero, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Citric acid; Fertilization in vitro; Fructose; Infertility, male; L Carnitine; Oligospermia diagnosis; Oligospermia epidemiology

Indexed keywords

ARTICLE; BIOCHEMISTRY; CHEMISTRY; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; HUMAN; INCIDENCE; ITALY; MALE; METHODOLOGY; OLIGOSPERMIA; PH; SPERM;

BIOCHEMISTRY; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYDROGEN-ION CONCENTRATION; INCIDENCE; ITALY; MALE; OLIGOSPERMIA; SEMEN;

EID: 0034153254     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. 1; Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet 1978;2(8085):366.
2. Steptoe PC, Edwards RG, Walters DE. Observations on 767 clinical pregnancies and 500 births after human in vitro fertilization. Hum Reprod 1986;1(2):89-94.
3. Cohen J, Fehilly CB, Fishel SB, Edwards RG, Hewitt J, Rowland GF et al. Male infertility successfully treated by in vitro fertilization. Lancet 1984;1(8388):1239-40.
4. Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 1992;340(8810):17-8.
5. Temple-Smith PD, Southwick GJ, Yates CA, Trounson AO, de Kretser DM. Human pregnancy by in vitro fertilization (IVF) using sperm aspirated from the epididymis. J in vitro Fert Embryo Transf 1985;2 (3):119-22.
6. Devroey P, Liu J, Nagy Z, Tournaye H, Silber SJ, Van Steirteghem AC. Normal fertilization of human oocytes after testicular sperm extraction and intracytoplasmic sperm injection. Fertil Steril 1994;62(3): 639-41.
7. Silber SJ, Van Steirteghem AC, Liu J, Nagy Z, Tournaye H, Devroey P. High fertilization and pregnancy rate after intracytoplasmic sperm injection with spermatozoa obtained from testicle biopsy. Hum Reprod 1995;10(1):148-52.
8. Silber SJ. The use of epididymal sperm for the treatment of male infertility. Baillieries Clin Obstet Gynaecol 1997;11(4):739-52.
9. Schlegel PN, Palermo GD, Goldstein M, Menendez S, Zaninovic N, Veeck LL et al. Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia. Urology 1997;49(3):435-40.
10. Devroey P. Clinical application of new micromanipulative technologies to treat the male. Hum Reprod 1998;13(3):112-22; discussion 123-6.
11. nd edition. Cambridge: Cambridge University Press, 1987.
12. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 3rd edition. Cambridge: Cambridge University Press, 1992.
13. Dondero F, Sciarra F, Isidori A. Statistical evaluation of the relationships between plasma testosterone and seminal fructose. Folia Endocrinol 1970;23(5):559-65.
14. Dondero F, Sciarra F, Isidori A. Evaluation of relationship between plasma testosterone and human seminal citric acid. Fertil Steril 1972; 23(3):168-71.
15. Soufir JC, Marson J, Jouannet P. Free L-carnitine in human seminal plasma. Int J Androl 1981;4(3):388-97.
16. Tomamichel GR, Bandhauer K. Seminal carnitine content in obstructive azoospermia. Correlation with the anatomic level of obstruction J Androl 1986;7:328-30.
17. Luzzana M, Perrella M, Rossi-Bernardi L. An electromedic method for measurement of small pH changes in biological systems. Anal Biochem 1971;43(2):556-63.
18. Rossi T, Mazzilli F, Sarandrea N, Rapone S, Dondero F. The application of the differential pH method to the biochemical evaluation of seminal plasma. Clin Biochem 1997; 30(2):143-8.
19. Papadimas J, Papadopoulou F, Ioannidis S, Spanos E, Tarlatzis B, Bontis J et al. Azoospermia: clinical, hormonal, and biochemical investigation. Arch Androl 1996;37(2):97-102.
20. Barak M, Calderon I, Abramovici H, Gruener N, Yavez H, Paz G et al. The use of a seminal vesicle specific protein (MSH-5 antigen) for diagnosis of agenesis of vas deferens and seminal vesicles in azoospermic men. J Androl 1994;15(6):603-7.
21. Takihara H. The treatment of obstructive azoospermia in male infertility: Past, present, and future. Urology 1998; 51(5A Suppl):150-5.
22. Stanwell-Smith RE, Hendry WF. The prognosis of male subfertility: A survey of 1025 men referred to a fertility clinic. Br J Urol 1984;56: 422-8.
23. Saeed S, Khan FA, Khan DA, Naveed AK, Ahmad M. Demonstration of the site of obstruction in azoospermia by biochemical markers. J Pak Med Assoc 1994; 44(6): 140-2.
24. Singer R, Sagiv M, Segenreich E, Zukerman Z, Levinsky H. Some characteristics of azoospermic human semen. Int J Fertil 1992;37(1): 44-7.
25. Eigenmann J, Bandhauer K, Tomamichel G. Seminal carnitine concentration in obstructive azoospermia. Eur Urol 1994;26(2):134-6.
26. Kanavakis E, Tzetis M, Antoniadi T, Pistofidis G, Milligos S, Kattamis C. Cystic fibrosis mutation screening in CBAVD patients and men with obstructive azoospermia or severe oligozoospermia. Mol Hum Reprod 1998;4(4):333-7.
27. Johnson MD. Genetic risks of intracytoplasmic sperm injection in the treatment of male infertility: recommendations for genetic counseling and screening. Fertil Steril 1998;70(3):397-411.
28. Dondero F, Pozza D, Mazzilli F, Isidori A. Response of adnexal glands to testosterone stimulation in the normal adult male. Fertil Steril 1976; 27(7):806-11.
29. Mazzilli F, De Santis LM, Rossi T, Delfino M, Dondero F. Seminal and biochemical features in a subject with male phenotype and 46,XX genotype. Arch Ital Urol Androl 1997;69(1):55-9